Navigation Links
PDI, Inc. Appoints Molecular Diagnostics Leader to Board of Directors
Date:10/30/2013

PARSIPPANY, N.J., Oct. 30, 2013 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it has appointed molecular diagnostics industry veteran John M. Climaco, J.D., to its board of directors, bringing the board to seven members.

"As we continue to execute on our strategic vision of solidifying a position in the molecular diagnostics space, we welcome John's unparalleled business expertise in this market," said Nancy Lurker, chief executive officer of PDI, Inc. "John's role will be invaluable to the board as we continue to expand our footprint in this arena."

Mr. Climaco co-founded Axial Biotech, Inc., a venture-backed molecular diagnostics company specializing in spine disorders, in 2003, and served as the president, chief executive officer and board member until 2012. Under Mr. Climaco's leadership, the company partnered with companies including Medtronic, Johnson & Johnson and Smith & Nephew to successfully develop and commercialize ScoliScore™, the first molecular prognostic test in the orthopedic industry. Among other accolades, Orthopaedics This Week magazine recognized ScoliScore as the Best New Diagnostics Technology for Spine Care 2010, and the Utah Technology Council named ScoliScore as the 2009 Utah Innovation Award winner in biotechnology. In addition, ScoliScore and its benefits to patients have been featured in The New York Times, Chicago Tribune and on MSNBC, CNBC and many other media outlets.

Mr. Climaco currently serves as a director on the boards of DigiRad Corporation and Perma-Fix Environmental Services, Inc. Previously, he practiced corporate and tax law for six years with Fabian & Clendenin in Salt Lake City. Earlier, he held the role of director of programming for Quokka Sports, a venture-backed online media
'/>"/>

SOURCE PDI, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Securus Medical Group Raises $6.5M, Appoints New CEO
2. Abide Therapeutics Appoints Dr. Gary ONeill as Vice President of Biology
3. Nonin Medical Appoints Richard J. Eagle Vice President of Sales
4. Exagen Diagnostics Appoints New Board Member
5. VirtualScopics Board of Directors Appoints Eric Converse Interim Chief Executive Officer, Announces Resignation of Jeff Markin
6. Elekta appoints Niklas Savander as its next President and Chief Executive Officer
7. Neurotrope, Inc., Appoints Paul E. Freiman to the Companys Board of Directors
8. Glysure Appoints Justine McQuillan as European Director of Clinical Affairs
9. Prometheus Laboratories Appoints Chief Executive Officer
10. Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
11. Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 RadiologyAuction will have their first auction starting ... demonstrations at the end of the auction on May ... and Fuji Cr,s, Agfa and Sony, printers and GE ... Various imaging equipment will be available at later auctions ... years of buying and selling imaging equipment, the brokers ...
(Date:5/4/2015)...  Oncobiologics, Inc., a biotherapeutics company focused on ... completed the construction of its GMP commercial launch ... Cranbury, New Jersey . The ... to utilize multiple technologies that enable rapid deployment ... use of the latest single-use technologies, the facility ...
(Date:5/4/2015)... Calif. , May 4, 2015  Isis Pharmaceuticals, ... exclusive license agreement with Bayer HealthCare (Bayer) to develop ... thrombosis. Under the terms of the agreement, Isis is ... payments, including an immediate $100 million up-front payment and ... following a Phase 2 study in patients with compromised ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... -- Clinilabs, an early phase and specialty CRO that ... today announced that they have opened a second Phase ... 15,000 square foot Specialty Pharma Phase I Unit features ... bioanalytic laboratory, pharmacy, and exam rooms. Since ...
... Inc. (NASDAQ: GNVC ) announced today that on ... of its common stock to Cynthia Collins, its newly appointed ... by the Compensation Committee of GenVec,s Board of Directors and ... material to Ms. Collins,s acceptance of employment with GenVec in ...
Cached Medicine Technology:Clinilabs Opens Phase I Unit In Eatontown, New Jersey 2GenVec Reports Inducement Award 2
(Date:5/4/2015)... “ LiveSchool ” was featured on ... a look at the latest and coolest applications on ... the host of AppWatch and technology expert, conducted the ... allows teachers to reward students with good behavior. , ... in the classroom. And the good people at ...
(Date:5/4/2015)... 2015 The opportunity for children to dream ... the motivating forces behind The Fairy Godmother Next Door, a ... Amy L. Stark. , The inspiration for the enchanting story ... comes from Stark’s desire to be a fairy godmother. , ... godmother to my neighbors’ children since they were born. We ...
(Date:5/4/2015)... 2015 The U.S. healthcare worker shortage ... the ranks of senior citizens (1) and 27 million ... over-burdened healthcare system. Additionally, as older healthcare employees retire, ... Per the U.S. Census Bureau, the number of American ... by 2050 while those 25 to 54 will likely ...
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... New findings released today from a ... show that people diagnosed with a brain tumor needed ... clinical trials, at the time of diagnosis, and had ... about their course of treatment. The release of these ... brain tumor volunteer network, the ABTA CommYOUnity™, dedicated to ...
Breaking Medicine News(10 mins):Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3
... HealthDay Reporter , TUESDAY, March 6 (HealthDay News) ... disorders, especially post-traumatic stress disorder, are more likely than ... new study finds. Use of these opioid pain ... addictive and cause more serious problems, researchers say. ...
... Most stroke patients undergo both CT and MRI brain scans, ... stroke care in the United States, a new study indicates. ... 600,000 patients diagnosed with stroke between 1999 and 2008 in ... who had MRI scans also had CT brain scans. ...
... 6 (HealthDay News) -- When it comes to wine, a new ... lost on many consumers. The professionals seem to have a ... Penn State University explained. As a result, wine experts are able ... other people just can,t taste. "What we found is that ...
... of evading the drugs used by oncologists to try and eliminate ... , Now, researchers at UCLA,s Jonsson ... gets around an inhibitor, Zelboraf, which targets the mutated BRAF gene. ... that encodes proteins, called the exome, Jonsson Cancer Center scientists discovered ...
... 2012) Researchers at Moffitt Cancer Center and colleagues from ... Kingdom have used two genome-wide association studies (GWAS) one ... detect a novel set of genes found to be associated ... the door to new therapies for treating epithelial ovarian cancer ...
... research from Carnegie Mellon University,s Marcel Just provides an ... and communication disorders to restricted interests and gives ... Autism has long been a scientific enigma, mainly ... now. Published in the journal Neuroscience and ...
Cached Medicine News:Health News:Narcotic Painkillers Another Threat to Traumatized War Vets: Study 2Health News:Narcotic Painkillers Another Threat to Traumatized War Vets: Study 3Health News:Brain Scans Overused on U.S. Stroke Patients, Study Says 2Health News:Wine Ratings May Be Meaningless for Most People 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 3Health News:Researchers find possible genetic keys to surviving epithelial ovarian cancer 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 2Health News:New brain imaging and computer modeling predicts autistic brain activity and behavior 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: